Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-29 4:29 pm Purchase | 13G | EDESA BIOTECH INC EDSA | Velan Capital Investment Management LP | 63,492 1.97% | 63,492 (New Position) | View |
| 2024-01-16 5:03 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Pardeep Nijhawan Medicine Professional Corp | 630,012 19.3% | 630,012 (New Position) | View |
| 2023-08-21 5:01 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Pardeep Nijhawan Medicine Professional Corp | 4,584,894 20.9% | 166,536 (+3.77%) | View |
| 2023-01-13 5:28 pm Sale | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 1,748,970 9% | -253,598 (-12.66%) | View |
| 2023-01-06 4:08 pm Purchase | 13G | EDESA BIOTECH INC EDSA | Velan Capital Investment Management LP | 1,777,776 8.78% | 1,777,776 (New Position) | View |
| 2022-11-08 12:18 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Pardeep Nijhawan Medicine Professional Corp | 4,418,358 22.1% | 1,500,681 (+51.43%) | View |
| 2020-09-18 08:00 am Purchase | 13D | EDESA BIOTECH INC EDSA | Edesa Biotech Inc. EDSA | 3,317,207 34.4% | 3,317,207 (New Position) | View |
| 2020-02-11 06:41 am Unchanged | 13G | EDESA BIOTECH INC EDSA | INTRACOASTAL CAPITAL LLC | 0 0% | 0 (Unchanged) | View |
| 2020-01-22 7:08 pm Purchase | 13D | EDESA BIOTECH INC EDSA | 10379085 Canada Inc. | 690,843 7.8% | 15,625 (+2.31%) | View |
| 2020-01-16 6:29 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Pardeep Nijhawan Medicine Professional Corp | 2,917,677 32.8% | 2,917,677 (New Position) | View |
| 2020-01-16 4:33 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 2,002,568 22.6% | 140,625 (+7.55%) | View |
| 2019-09-09 9:10 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Inveready Innvierte Biotech II S.C.R. S.A | 531,986 7.1% | 29,031 (+5.77%) | View |
| 2019-09-09 9:07 pm Purchase | 13D | EDESA BIOTECH INC EDSA | 10379085 Canada Inc. | 675,218 9% | 36,846 (+5.77%) | View |
| 2019-08-19 5:05 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Nijhawan Pardeep | 2,868,175 38.2% | 161,116 (+5.95%) | View |
| 2019-08-19 5:05 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 1,861,943 24.8% | 101,606 (+5.77%) | View |
| 2019-06-25 3:23 pm Purchase | 13D | EDESA BIOTECH INC EDSA | 10379085 Canada Inc. | 638,372 8.9% | 638,372 (New Position) | View |
| 2019-06-19 3:07 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Inveready Innvierte Biotech II S.C.R. S.A | 502,955 7% | 502,955 (New Position) | View |
| 2019-06-19 08:12 am Purchase | 13D | EDESA BIOTECH INC EDSA | Nijhawan Pardeep | 2,707,059 37.9% | 2,707,059 (New Position) | View |
| 2019-06-17 3:38 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 1,760,337 24.7% | 1,760,337 (New Position) | View |